Emerging Pharmacologic Treatments for Alcohol- Associated Hepatitis Current Status and Future Landscape

被引:0
|
作者
Morgan, Timothy R. [1 ,2 ]
机构
[1] VA Long Beach Healthcare Syst, Med Serv Gastroenterol, 5901 East Seventh St, Long Beach, CA 90822 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA USA
关键词
Alcohol-associated hepatitis; Interleukin-22; Fecal microbiota transfer; Larsucosterol; Rifaximin; Phage therapy; N-ACETYLCYSTEINE; LIVER-INJURY; MICROBIOTA; CORTICOSTEROIDS; REGENERATION; SURVIVAL; IMPROVES; FAILURE; MODEL;
D O I
10.1016/j.cld.2024.06.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Multiple treatments have shown preliminary efficacy for the treatment of alcoholic hepatitis. These treatments address different pathophysiologic pathways, including hepatocyte regeneration, changing the microbiome, and antioxidants. Many of these approaches use relatively inexpensive treatments that are currently available, although not for alcoholic hepatitis. Other treatments would require support from pharmaceutic companies. Given the burden of AH in many countries, the potential adverse events with corticosteroid treatment (or contraindications to corticosteroids), and the positive preliminary data with several agents, trials of new agents for the treatment of AH are reasonable.
引用
收藏
页码:747 / 760
页数:14
相关论文
共 50 条
  • [41] Hepatitis E vaccine: current status and future prospects
    Amini-Bavil-Olyaee, Samad
    Trautwein, Christian
    Tacke, Frank
    FUTURE VIROLOGY, 2009, 4 (02) : 143 - 154
  • [42] Pharmacological treatments for methamphetamine addiction: current status and future directions
    Ballester, Javier
    Valentine, Gerald
    Sofuoglu, Mehmet
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (03) : 305 - 314
  • [43] Psychosocial treatments for pathological gambling: Current status and future directions
    Petry, NM
    PSYCHIATRIC ANNALS, 2002, 32 (03) : 192 - 196
  • [44] Current Trend and Future Status of Macular Diseases and Their Treatments in Japan
    Kume, Atsuki
    Kashiwagi, Kenji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [45] Current and future treatments of HIV-associated dyslipidemia
    Bennett, M. T.
    Johns, K. W.
    Bondy, G. P.
    FUTURE LIPIDOLOGY, 2008, 3 (02): : 175 - 188
  • [46] UNDERUTILIZATION OF PHARMACOLOGIC THERAPY FOR ALCOHOL USE DISORDER (AUD) IN PATIENTS HOSPITALIZED WITH ALCOHOL-ASSOCIATED HEPATITIS
    Tien, Christine
    Xu, Mimi
    Kong, Niwen
    Lehoang, David
    Pimienta, Michael
    Ayyala, Divya
    Narala, Rachan
    Terrault, Norah
    HEPATOLOGY, 2023, 78 : S1667 - S1668
  • [47] Emerging desalination technologies: Current status, challenges and future trends
    Ahmed, Farah Ejaz
    Khalil, Abdullah
    Hilal, Nidal
    Desalination, 2021, 517
  • [48] Emerging desalination technologies: Current status, challenges and future trends
    Ahmed, Farah Ejaz
    Khalil, Abdullah
    Hilal, Nidal
    DESALINATION, 2021, 517
  • [49] Apigenin as an emerging hepatoprotective agent: current status and future perspectives
    Wang, Cheng
    Feng, Xiaoli
    Li, Wen
    Chen, Li
    Wang, Xinming
    Lan, Yimiao
    Tang, Rong
    Jiang, Ting
    Zheng, Lingli
    Liu, Gang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Microplastics as an emerging threat to amphibians: Current status and future perspectives
    Rahman, Md Mizanur
    Kim, Eung-Sam
    Sung, Ha-Cheol
    HELIYON, 2024, 10 (07)